Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
6.74
-0.32 (-4.53%)
May 13, 2025, 4:00 PM - Market closed
Alpha Teknova Revenue
Alpha Teknova had revenue of $9.80M in the quarter ending March 31, 2025, with 5.44% growth. This brings the company's revenue in the last twelve months to $38.25M, up 3.79% year-over-year. In the year 2024, Alpha Teknova had annual revenue of $37.75M with 2.89% growth.
Revenue (ttm)
$38.25M
Revenue Growth
+3.79%
P/S Ratio
8.79
Revenue / Employee
$221,098
Employees
173
Market Cap
360.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.75M | 1.06M | 2.89% |
Dec 31, 2023 | 36.68M | -4.74M | -11.43% |
Dec 31, 2022 | 41.42M | 4.53M | 12.27% |
Dec 31, 2021 | 36.89M | 5.60M | 17.88% |
Dec 31, 2020 | 31.30M | 10.52M | 50.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TKNO News
- 3 days ago - Alpha Teknova, Inc. (TKNO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Teknova Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 19 days ago - Teknova to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 7 weeks ago - Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - GlobeNewsWire
- 2 months ago - Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - GlobeNewsWire
- 2 months ago - Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - GlobeNewsWire